Through 6 months (Effectiveness) | Baseline value—control clinics | Slope of control clinics (95% CI) | p value (pre-post within control clinics) | Baseline value—intervention clinics | Slope of intervention clinics (95% CI) | p value (pre-post within intervention clinics) | Slope of intervention minus control (95% CI) | p value (difference between intervention—control groups) |
---|---|---|---|---|---|---|---|---|
Proportion of patients with consistent opioid Rx a | 0.014 | − 0.0001 (0.0000, − 0.00002) | 0.152 | 0.013 | − 0.0002 (− 0.0001, − 0.0003) | 0.011 | − 0.0001 (0.0000, − 0.0002) | 0.237 |
Proportion with mental health screen b | 0.220 | 0.029 (0.052, 0.006) | 0.020 | 0.226 | 0.058 (0.079, 0.038) | 0.009 | 0.029 (0.053, 0.005) | 0.024 |
Proportion with urine drug testing b | 0.374 | 0.011 (0.035, − 0.013) | 0.025 | 0.399 | 0.041 (0.061, 0.020) | 0.009 | 0.029 (0.050, 0.008) | 0.011 |
Proportion with treatment agreement b | 0.368 | 0.029 (0.050, 0.009) | 0.009 | 0.428 | 0.059 (0.080, 0.038) | 0.010 | 0.03 (0.051, 0.008) | 0.012 |
Average morphine- equivalent daily dose (MEDD) b | 58.8 | 0.245 (−2.08, 2.57) | 0.646 | 86.3 | −0.337 (1.07, −1.75) | 0.449 | −0.581 (0.75, − 1.92) | 0.425 |
Proportion with MEDD > 120 b | 0.137 | − 0.002 (− 0.001, − 0.004) | 0.249 | 0.215 | −0.004 (− 0.002, − 0.005) | 0.045 | −0.001 (0.003, − 0.006) | 0.624 |
Proportion with co-prescribed benzodiazepines b | 0.055 | 0.001 (− 0.006, 0.008) | 0.654 | 0.080 | − 0.001 (0.006, − 0.007) | 0.637 | − 0.002 (0.000, − 0.003) | 0.019 |